drugset

drugset / Trial / NCT00925847

Effect of Lithium Carbonate in Patients With Amyotrophic Lateral Sclerosis

NCT00925847 ↗

Phase 2 Completed 23 enrolled Assistance Publique - Hôpitaux de Paris

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to determine whether lithium is safe and effective in the treatment of ALS

Timeline

Start: 2009-06
Primary completion: 2011-04
Completion: 2011-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lithium	Unknown	400 mg	Oral

Indications